Institutionelle Investoren in Eloxx Pharmaceuticals, Inc. (ELOX)

Neutral Alle meldenden Fondsgesellschaften (SEC-Formular 13F) und deren Investment in dieses Wertpapier über die letzten 4 Quartale. Zusätzlich aktuell von 5 Mutual Funds/ETFs gehalten (N-PORT).
Aktien-Detail Fonds-Verzeichnis
Fonds2026/Q2
Investment ($)QoQ ($)QoQ (%)
40.247.672 $
Nantahala Capital Management, LLC11.104.000 $
Siren, L.L.C.5.552.000 $
EcoR1 Capital, LLC5.552.000 $
Aberdeen Group plc5.552.000 $
Samsara BioCapital, LLC5.552.000 $
Stonepine Capital Management, LLC5.512.581 $
VANGUARD CAPITAL MANAGEMENT LLC1.092.078 $
VANGUARD FIDUCIARY TRUST CO147.156 $
SEVEN GRAND MANAGERS, LLC138.800 $
MORGAN STANLEY21.431 $
Vanguard Global Advisers, LLC9.966 $
UBS Group AG8.842 $
WELLS FARGO & COMPANY/MN1.749 $
Pioneer Family Office, LLC1.332 $
ROYAL BANK OF CANADA1.000 $
Altshuler Shaham Ltd347 $
BARCLAYS PLC167 $
Towne Trust Company, N.A69 $
Activest Wealth Management56 $
CITIGROUP INC56 $
SBI Securities Co., Ltd.28 $
Point Nemo Capital, LLC14 $
40.247.672 $
Erweitert ×